Normalization of obesity-associated insulin resistance through immunotherapy - sprookjes - yvandenbroek - TriplyDB

Normalization of obesity-associated insulin resistance through immunotherapy

Normalization of obesity-associated insulin resistance through immunotherapy

http://www.wikidata.org/entity/Q34994222

about

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies Human nutrition, the gut microbiome and the immune system Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease Exploring the Homeostatic and Sensory Roles of the Immune System Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders Adipose tissue macrophages: going off track during obesity The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases Linking obesity with type 2 diabetes: the role of T-bet Role of T cells in type 2 diabetic nephropathy Metabolic regulation of regulatory T cell development and function Adipose tissue immunity and cancer Adipose tissue as a potential source of hematopoietic stem/progenitor cells The immune system's involvement in obesity-driven type 2 diabetes The outliers become a stampede as immunometabolism reaches a tipping point (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights Neuroinflammation in overnutrition-induced diseases The immune cells in adipose tissue Immune cells link obesity-associated type 2 diabetes and periodontitis The immune system as a sensor of the metabolic state Inhibition of Inflammation and iNOS Improves Lymphatic Function in Obesity.Gammadelta T cells are reduced and rendered unresponsive by hyperglycemia and chronic TNFalpha in mouse models of obesity and metabolic disease Lymphocyte roles in metabolic dysfunction: of men and mice Metainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune Responses Gut microbiota and immune crosstalk in metabolic disease Multiple Sclerosis and Obesity: Possible Roles of Adipokines Type 2 responses at the interface between immunity and fat metabolism Immunological contributions to adipose tissue homeostasis Endoplasmic reticulum stress and atherosclerosis Genetics, pathogenesis and clinical interventions in type 1 diabetes The effects of diet-induced obesity on B cell function Use of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin Secretion Drivers of age-related inflammation and strategies for healthspan extension Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

P2860

Q24598772-B86F5E4D-9483-4D50-8D99-1A8E0736AE26 Q24620449-A4F86B6A-4BC5-416F-98BD-ABECCD66FDC2 Q24629044-ED4C7EC2-11D1-4AD5-AE9A-D2B3EB9B64FA Q24633352-9B8B24C1-DD69-4956-9291-A892AD1D3A23 Q26738646-DB2C3858-EE97-48D3-803A-297CBB77C5A6 Q26750366-8E26EBE9-3A42-4C90-A793-4EF6B90C225A Q26750746-A9CD00C0-AE2B-4BE2-A381-2D7219BDDE98 Q26752618-CEC04B11-F6DA-44B6-8DB6-1042FA9B2B9D Q26768692-96D12BA5-11BA-40CD-A0F2-6EC2DC967CEA Q26798273-EB417975-0AFD-449C-9F30-7075D8B45099 Q26801371-B386B3ED-29CD-4BFF-8675-62D47B788445 Q26825467-58A9600C-CD30-4196-BC9E-AB9191BDB902 Q26830915-7CC947FB-F431-4CD8-9C4A-08E9DEA778C2 Q26849691-11160023-C7B6-4FB1-996B-941361BAAFEC Q26852681-7BC2AAC3-EBCA-4501-A5F9-C6BF476378E5 Q26862654-B55D7F19-3221-4558-900E-A63069E1FF1C Q26991965-F5252EA1-A81A-4284-A55D-390DD484B625 Q27001164-B8767AC9-FEB0-4B65-AE5A-BC02ADA110C5 Q27005951-7E1FE08D-A648-4838-A4B9-7A7F2FC51DF2 Q27013554-EA9C7FFD-E9EE-4AA0-9F1E-898BCA47E2D1 Q27013624-92FD414F-AFA9-40A8-8A2D-786D39A9335D Q27023262-EB70A2B3-AC23-4C58-806F-AB65C28A0EC3 Q27024696-BC0F4075-61A7-4A62-B090-CEF067046C2C Q27026072-F79BB22F-3D74-47E6-BBCA-123272AC5D6E Q27300878-A03E5D6E-EC62-4853-A170-44F47832F5A6 Q27324312-B2766F5C-0EF6-4146-9C55-D793C0A71E2F Q27687298-1B648EEB-9EC6-42EA-A6FC-801556A4610B Q28075968-793B3005-BF07-4481-B7C0-5E92BF89A1E6 Q28078180-15C8AEEA-34FE-46DE-AF24-2DB5DDDB09D9 Q28078518-DA5DDE0E-AC2C-4A22-B351-C31AE1B3DB56 Q28082245-16A89DD9-C3C5-4127-B08E-D4428B889253 Q28084995-96C496D5-9BEF-48A6-B133-FA6936A61F04 Q28279152-505EEFEC-2500-4AD6-B203-A8BE2BC62D2C Q28281029-42F2E267-C01C-4C5B-8FDB-E8EA55BB678E Q28383934-E39FC67A-3249-42CD-B49A-5E2C84A7BE50 Q28551169-3F704043-70BE-40F1-94F7-224ABBE10613 Q28649560-7D585B3D-E436-4379-AE7D-98A02CE7B0BE Q28744643-366A60F7-B6DB-4B4F-BE22-430707C095A6 Q28830272-205F7A7B-0511-4E07-860C-8FD89145F072 Q29616026-26F1C01C-8E91-4073-BA9B-E7F99EA1FB91

P2860

Normalization of obesity-associated insulin resistance through immunotherapy

http://www.wikidata.org/entity/Q34994222

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Normalization of obesity-associated insulin resistance through immunotherapy

@ast

Normalization of obesity-associated insulin resistance through immunotherapy

@en

Normalization of obesity-associated insulin resistance through immunotherapy

@nl

type

label

Normalization of obesity-associated insulin resistance through immunotherapy

@ast

Normalization of obesity-associated insulin resistance through immunotherapy

@en

Normalization of obesity-associated insulin resistance through immunotherapy

@nl

prefLabel

Normalization of obesity-associated insulin resistance through immunotherapy

@ast

Normalization of obesity-associated insulin resistance through immunotherapy

@en

Normalization of obesity-associated insulin resistance through immunotherapy

@nl

P1433

Q34994222-FE696C18-9D2E-4AC7-AD77-62AD4563E8BD

P1476

Q34994222-597E1981-2541-4452-BD46-45620CDB3B35

P2093

Q34994222-04093CF2-9A8B-4F9A-AAAC-DC78E6070512

Q34994222-1A9C319E-EFC8-4561-9390-0FCEC4FDFCA5

Q34994222-205C9C1C-2139-4A3F-A3DA-9A64DA7A1053

Q34994222-3933EBEE-C723-4A0A-BFEA-FA19D3ABBF78

Q34994222-3F1BDC50-5023-44E1-BDE5-9E0D2CABF18A

Q34994222-4D7ED4EC-DA8E-404D-AFD0-E1AF58AF2065

Q34994222-5E9858A1-41BF-409D-9EF7-755CF84EAB39

Q34994222-644F34A8-19B7-4504-94F4-21259F139C36

Q34994222-6DCFDDFE-D0EB-438F-BB07-147B217F57A5

Q34994222-72C6750E-C1F5-4B5A-A4F7-4283332F410B

P2860

Q34994222-0439C420-CFE2-4130-83AB-19332EFA26E1

Q34994222-08EBD6E5-F1BF-4D19-BBF7-258542054003

Q34994222-0B14205B-A0AD-4707-B724-E9F678A20CFA

Q34994222-1CDE2745-31A8-402B-A2C0-7B39DF8E4F58

Q34994222-1D3BBF55-1083-4A78-8446-AB386BB7C236

Q34994222-1DBC4A43-6662-4079-827D-F219E4438B03

Q34994222-2477D2B5-48C9-473E-90E6-23EB828DD96E

Q34994222-24C01640-777D-4758-9C43-A37273CDCFE8

Q34994222-27499914-982E-416C-81A5-83A8D2096243

Q34994222-2A60ED27-21EE-4E18-8035-308367DFCF89

P2888

Q34994222-382F8791-E856-4641-993E-883A1F6DB80B

P304

Q34994222-ECB1D8D4-0987-4D81-AE72-2648600790F7

P31

Q34994222-2E56BB54-AED1-442F-8281-36EBAC658236

P356

Q34994222-15842DFD-7E9C-4CFE-862A-826DB8265863

P407

Q34994222-643821AC-0800-43FE-B880-EF120798D88B

P433

Q34994222-07217BC3-9406-4DA7-8419-6379938FE045

P478

Q34994222-1C222240-F0A6-4436-867D-E266767DD976

P50

Q34994222-228AFBBB-D52F-4CD2-8506-C60971F2415E

Q34994222-23DD10C8-BB3C-40E2-BC61-A804D7E3F6C9

P577

Q34994222-37593CA1-D7E5-44FD-AACC-3F5AF5330224

P5875

Q34994222-C569DE6F-E3E8-4DF3-AA52-E72BCDF879B4

P698

Q34994222-1EF81171-4BF5-435F-B06C-06769100891F

P921

Q34994222-13364F61-9685-4F99-8FD1-AFF02817ED02

Q34994222-5262B2FA-E220-47A8-B4A2-58924B0AF78B

Q34994222-AFE7BD76-8A2A-4BCD-BF3B-AB30408AC367

P932

Q34994222-3E77B5C6-9089-4B42-954A-D1ED0CCB7081

P356

P1433

Nature Medicine

P1476

Normalization of obesity-associated insulin resistance through immunotherapy

@en

P2093

Daniel Winer

http://www.w3.org/2001/XMLSchema#string

Dorothy Truong

http://www.w3.org/2001/XMLSchema#string

Edgar Engleman

http://www.w3.org/2001/XMLSchema#string

Fabrizio Mastronardi

http://www.w3.org/2001/XMLSchema#string

Geoffrey Paltser

http://www.w3.org/2001/XMLSchema#string

H-Michael Dosch

http://www.w3.org/2001/XMLSchema#string

Hubert Tsui

http://www.w3.org/2001/XMLSchema#string

Jasmine Bahrami

http://www.w3.org/2001/XMLSchema#string

Julian Zielenski

http://www.w3.org/2001/XMLSchema#string

Ruslan Dorfman

http://www.w3.org/2001/XMLSchema#string

P2860

A novel transcription factor, T-bet, directs Th1 lineage commitment

Inflammation and metabolic disorders

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene

A function for interleukin 2 in Foxp3-expressing regulatory T cells

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

Mechanisms linking obesity to insulin resistance and type 2 diabetes

Macrophage activation and polarization

P2888

P304

921-929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Daniel J. Drucker

P577

2009-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26696724

http://www.w3.org/2001/XMLSchema#string

P698

19633657

http://www.w3.org/2001/XMLSchema#string

P921

P932

3063199

http://www.w3.org/2001/XMLSchema#string